Gilead Sciences and Sovaldi Case Strategy Memo and Business Letter – Description
Prompt: Case 2.2: Gilead Sciences and Solvadi; The Cost of a Cure (A)
o Requirements: Please respond to the following. Responses should be a minimum of 500 words, separate from the cover sheet and reference list.
▪ Please respond in writing to the issues presented in this case by preparing two documents: a communication strategy memo and a professional
business letter.
▪ In preparing these documents, you may assume one of two roles: you may identify yourself as a Gilead senior manager who has been asked to
provide advice to Vice President Amy Flood regarding the issues they and their company are facing. Or, you may identify yourself as an external
management consultant who the company has asked to provide advice to them.
▪ Either way, you must prepare a strategy memo addressed to Ms. Flood that summarizes the details of the case, identifies critical issues, discusses their implications (what they mean and why they matter), offers specific recommendations for action (assigning ownership and suspense dates for each), and shows how to communicate the solution to all who are affected by the recommendations.
▪ You must also prepare a professional business letter for the signature of John F. Milligan, Gilead Sciences Chief Executive Officer. That document should be addressed either to all Sovaldi patients or to another group of key stakeholders, explaining what happened and the actions the company is taking. If you have questions about either of these documents, please consult your instructor.
Resource Inventory:
O’Rourke, J. S. (2019). Management communication: A case analysis approach. (6th ed.).
Routledge. ISBN: 978-0-367-17812-3
The post Gilead Sciences and Sovaldi Case Strategy Memo and Business Letter first appeared on .
